The article evaluates which of Medtronic or Thermo Fisher offers greater upside as a healthcare turnaround candidate
Executive summary: A Yahoo Finance article compares the turnaround prospects of Medtronic and Thermo Fisher, asking which offers more upside. The comparison helps investors assess which healthcare turnaround may deliver stronger returns and where to allocate capital.
Who is involved: Medtronic, Thermo Fisher, and investors evaluating healthcare stocks.
Likely next: Investors will monitor upcoming quarterly results, pipeline developments, and market reactions to gauge which company delivers stronger upside.
The piece examines the relative upside potential of Medtronic and Thermo Fisher as healthcare turnaround candidates. It outlines the comparative factors that analysts consider when assessing turnaround success. The article aims to help investors decide which company may offer better returns.
Timeline
- — Medtronic vs. Thermo Fisher: Which Healthcare Turnaround Offers More Upside? (Yahoo Finance)
- — Medtronic announces cash dividend for second quarter of fiscal year 2027 (PR Newswire)
Key entities
Sources
- Medtronic vs. Thermo Fisher: Which Healthcare Turnaround Offers More Upside? — Yahoo Finance
- Medtronic announces cash dividend for second quarter of fiscal year 2027 — PR Newswire